Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A-1 Exosomes
- Development stage
- Unknown
- Lead developer
- Celltex Therapeutics
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Subcutaneous, Intraperitoneal, Intratumoral, Intraarticular, Intranasal, Oral, Inhalation, In Situ
01
Overview
A-1 Exosomes is an exosome-based biologic therapy developed by Celltex Therapeutics in collaboration with the Texas A&M Institute for Regenerative Medicine. The therapy utilizes exosomes derived from autologous mesenchymal stem cells (MSCs), which are small extracellular vesicles that facilitate intercellular communication by delivering bioactive molecules. In the context of Alzheimer's disease, A-1 Exosomes are designed to leverage the anti-inflammatory and regenerative properties of MSC-derived vesicles to reduce neuroinflammation and prevent tissue damage in the brain through paracrine signaling. The candidate is currently being evaluated in Phase I clinical development as a cell-free alternative to traditional stem cell therapies.
- Brand names
- A-1 ExosomesA1 ExosomesA 1 Exosomes
- Other names
- Mesenchymal Stem Cells-Derived ExosomesAutologous MSC-derived exosomesCelltex exosomes
Beyond the preview
Go deeper on A-1 Exosomes.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on A-1 Exosomes.